Should high hTg levels in the absence of iodine uptake be treated?

被引：6

作者：

Britton, KE

Foley, RR

Chew, SL

机构：

[1] St Bartholomews Hosp, Dept Nucl Med, London EC1A 7BE, England

[2] St Bartholomews Hosp, Dept Endocrinol, London EC1A 7BE, England

来源：

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2003年 / 30卷 / 05期

关键词：

D O I：

10.1007/s00259-003-1139-8

中图分类号：

R8 [特种医学]; R445 [影像诊断学];

学科分类号：

1002 ; 100207 ; 1009 ;

摘要：

引用

页码：794 / 795

页数：2

共 12 条

[1] Should high hTg levels in the absence of iodine uptake be treated? Against [J].

Biermann, M ;

Schober, O .

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2003, 30 (01) :160-163

[2]

Britton KE, 1999, EUR J NUCL MED, V26, P1013

[3]

BRITTON KE, 1987, CANCER SURV, V6, P246

[4]

Gulzar Z, 2001, Endocr Pract, V7, P244

[5] 123I as a diagnostic tracer in the management of thyroid cancer [J].

Kalinyak, JE .

NUCLEAR MEDICINE COMMUNICATIONS, 2002, 23 (06) :509-511

[6] Decreased uptake of therapeutic doses of iodine-131 after 185-MBq iodine-131 diagnostic imaging for thyroid remnants in differentiated thyroid carcinoma [J].

Leger, FA ;

Izembart, M ;

Dagousset, F ;

Barritault, L ;

Baillet, G ;

Chevalier, A ;

Clerc, J .

EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 1998, 25 (03) :242-246

[7] Should high hTg levels in the absence of iodine uptake be treated? For [J].

Lind, P .

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2003, 30 (01) :157-160

[8]

MAXON HR, 1993, J NUCL MED, V25, P242

[9]

Park HM, 2002, J NUCL MED, V43, P77

[10]

Sarkar SD, 2002, J NUCL MED, V43, P632

← 1 2 →